Bioconversion products of 27-hydroxy avermectin
Both isomers of 27-hydroxy avermectin aglycones represented by compound (I> wherein the broken line at the 22, 23-position indicates a single or double bond, R1 is present only when the broken line is a single bond, R1 is hydrogen, and the wavy line at the 27-position represents the A and B isome...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Both isomers of 27-hydroxy avermectin aglycones represented by compound (I> wherein the broken line at the 22, 23-position indicates a single or double bond, R1 is present only when the broken line is a single bond, R1 is hydrogen, and the wavy line at the 27-position represents the A and B isomers, are produced by cultivating a strain of the microorganism S. erythrea in a nutrient medium containing assimilable sources of nitrogen and carbon and an avermectin aglycone substrate under aerobic conditions until a substantial amount of compound (I) is produced and isolating the compound (I) so produced. Compound (I) may be converted to other avermectin derivatives, e.g. The compounds and the intermediates used to make them are highly potent antiparasitic, insecticidal and anthelmintic avermectin agents. |
---|